A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

Investigational Site Number: 002, Bologna, Italy

Investigational Site Number: 006, Brescia, Italy

Investigational Site Number: 004, Florence, Italy

Investigational Site Number: 001, Milan, Italy

Investigational Site Number: 010, Naples, Italy

Investigational Site Number: 011, Naples, Italy

Investigational Site Number: 005, Roma, Italy

Investigational Site Number: 009, Roma, Italy

Investigational Site Number: 014, Verona, Italy